The nuclear bile acid receptor FXR as a novel therapeutic target in cholestatic liver diseases: hype or hope?
Trauner
Michael
M
Laboratory of Experimental and Molecular Hepatology, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Medical University Graz, Graz, Austria.